3 months
Extended FDA Review Timeline for Ascendis’ Hormone Therapy
Ascendis Pharma, hormone therapy, FDA review, delay, 3 months extension.
Actionable Insights Powered by AI
Ascendis Pharma, hormone therapy, FDA review, delay, 3 months extension.